1 study found for:    7e11
Show Display Options
Rank Status Study
1 Unknown  Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
Condition: Metastatic Prostate Cancer
Intervention: Drug: 177Lu-CYT-500

Indicates status has not been verified in more than two years